Elias D, Sideris L, Pocard M, de Baere T, Dromain C, Lassau N, Lasser P
Department of Surgical Oncology, Institut Gustave Roussy, Cancer Center, 39 Rue Camille Desmoulins, 94805, Villejuif Cedex, France.
Ann Surg Oncol. 2005 Apr;12(4):298-302. doi: 10.1245/ASO.2005.03.020. Epub 2005 Mar 14.
When patients with resectable colorectal liver metastases (LM) are treated with percutaneous radiofrequency (RF), some unsuspected intrahepatic and extrahepatic metastases, detectable only at laparotomy, might be ignored and left untreated. This would result in a reduced cure rate. Our purpose was to discover the incidence of unsuspected and surgically treatable intrahepatic and extrahepatic metastases discovered at laparotomy.
The data of 506 patients who underwent a laparotomy and then a hepatectomy for colorectal LM were prospectively collected and retrospectively analyzed. All patients had undergone at least two types of preoperative liver imaging (but no fluorodeoxyglucose-positron emission tomography).
Unsuspected metastases were discovered at laparotomy in 209 patients (41.3%). There were extrahepatic metastases in 82 patients (16.2%), additional LM in 152 patients (30%), and both in 25 patients (4.9%). Liver palpation and intraoperative ultrasound allowed for detecting additional LM in 125 (24.7%) and 48 (9.4%) patients, respectively. All of them were resected. When only the 124 patients who presented with 1 to 3 LM measuring <3 cm in diameter (candidates for percutaneous RF) were considered, the results were similar. Moreover, the incidence of unsuspected metastases was similar when the periods of surgery (before and after January 1996) were considered.
Laparotomy permits discovery of and treatment with a curative intent of unsuspected intrahepatic or extrahepatic metastases in at least one third of patients with classically resectable colorectal LM. This does not support the use of percutaneous RF ablation instead of hepatic resection for this population, because it will result in an important survival decrease.
当可切除的结直肠癌肝转移(LM)患者接受经皮射频(RF)治疗时,一些仅在开腹手术时才能检测到的未被怀疑的肝内和肝外转移可能会被忽视而未得到治疗。这将导致治愈率降低。我们的目的是发现开腹手术时发现的未被怀疑且可手术治疗的肝内和肝外转移的发生率。
前瞻性收集并回顾性分析了506例行开腹手术然后肝切除术治疗结直肠癌肝转移患者的数据。所有患者均接受了至少两种类型的术前肝脏影像学检查(但未进行氟脱氧葡萄糖-正电子发射断层扫描)。
209例患者(41.3%)在开腹手术时发现了未被怀疑的转移。其中82例患者(16.2%)有肝外转移,152例患者(30%)有额外的肝转移,25例患者(4.9%)两者皆有。肝脏触诊和术中超声分别在125例(24.7%)和48例(9.4%)患者中检测到额外的肝转移。所有这些转移灶均被切除。当仅考虑124例直径<3 cm的1至3个肝转移灶的患者(适合经皮射频治疗)时,结果相似。此外,考虑手术时期(1996年1月前后)时,未被怀疑转移的发生率相似。
开腹手术能够发现并以治愈为目的治疗至少三分之一经典可切除的结直肠癌肝转移患者中未被怀疑的肝内或肝外转移。这并不支持对该人群使用经皮射频消融术替代肝切除术,因为这将导致生存率显著下降。